The most conscientious and progressive board leaders have moved well beyond a simple check-the-box compliance approach to a more rigorous process that is aimed at identifying ways the board can continually enhance the contribution it makes to the organization it is governing.
Corporate boards should take note that the situation at Progenics Pharmaceuticals has resulted in a proxy advisory firm validating a call for “shareholder board oversight.” Serving on a board that has been sighted for oversight by its investors could have an effect on future board appointments.
Composition of a board does not always guarantee effectiveness; what does are the personal attributes of the individual directors.
According to a new study by proxy advisory firm Institutional Shareholder Services released this week, the number of both women and ethnic minorities either joining or serving as directors at Russell 3000 companies hit a record high in 2019.
Survey by Corporate Board Member and Ernst & Young LLP shows that half of corporate directors report being unconvinced their boards have the appropriate resources to move their companies forward in this era of fast-paced technological change.